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1. Introduction 
The molecular mechanism of a great number of 
non-steroid hormones involves the direct participa- 
tion of CAMP and CAMP-regulated protein kinases 
in eukaryotic cells [ 1,2]. Through the action of CAMP- 
dependent protein kinases non-steroid hormones 
achieve the phosphorylation and functional modifica- 
tion of specific cellular proteins [3,4]. The potential 
significance of CAMP-mediated nuclear protein phos- 
phorylation in rat mammary tumors has become 
evident through studies on the regression of DMBA- 
induced rat mammary tumors [ 5,6] giving evidence 
that hormone-dependent umor regression might be 
due to an antagonistic relationship between steroid 
hormones and CAMP. The involvement, however, of 
cyclic nucleotides in the action of steroid hormones is 
not clear, but there is a considerable amount of 
evidence that an interrelationship may exist between 
steroid hormones and the CAMP-sensitive protein 
kinase system [7-91. 
An increasing number of experimental findings 
show that the amount of type I and type II protein 
Abbreviation: CAMP, adenosine 3’:5’-monophosphate 
Enzyme: CAMP-dependent protein kinase or ATP: protein 
phosphotiansferase (EC 2.7.1.37) 
This is paper 3 in a series on the role of the adenylyl cyclase- 
protein kinase system in human mammary tumors from the 
Laboratory of Experimental Endocrinology, Dept. of 
Gynecology, University of Base1 
EIsevierfNorth-Holland Biomedical Press 
kinase isozyme activity determines the response of 
specific stimuli in a given tissue [ 10,l l] as well as a 
selective, biological role for the two types of protein 
kinase isozymes. Ontogenetic studies suggest hat 
type II isozyme may be involved in the process of 
cellular differentiation [ 12,131, whereas type I 
isozyme is related to cell proliferation [ 141. 
In view of a possible involvement of CAMP-depen- 
dent protein kinase in cellular proliferation and 
differentiation, and in view of the reported decreased 
cellular levels of CAMP-dependent protein kinase and 
CAMP-binding activities as well as lower levels of 
CAMP in human mammary tumors in comparison to 
normal mammary tissue [ 15,161, we have characterized 
the major fractions of CAMP-dependent protein kinase 
activities in normal and neoplastic human breast 
tissue by ion exchange chromatography. Two major 
fractions have been identified and referred to as 
isozyme type I and type II CAMP-dependent protein 
kinase [ 171. These two isozymes differ mainly in 
their regulatory subunits [ 191; their catalytic sub- 
units are similar [20]. 
We have found that the isozyme ratio type I versus 
type II protein kinase is 2-fold higher in neoplastic 
human mammatry tissue as compared to normal 
breast tissue. With respect to the increased cellular 
densities of neoplastic mammary tissue [ 1.51 the total 
amount of CAMP-dependent protein kinase activity is 
not lower in neoplastic as compared to normal 
mammary tissue. A relative cellular increase of CAMP- 
dependent protein kinase isozyme type I in human 
mammary tumors as compared to normal breast 
tissue is reported. 
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2. Materials and methods 
All biochemical reagents were obtained from Sigma 
Chemical Co. Protamine sulfate was from Merck. 
[r-“P]ATP (2-10 Ci/mmol) was purchased from 
New England Nuclear and DEAE-cellulose from 
~atman (DE-52). 
Breast issue specimens were obtained from cancer 
patients during mastectomy, from biopsies (l-3 g 
tissue) and from control patients with simple dysplasia. 
Specimens were kept at 4°C on ice after excision and 
stored at -7O’C. Morphological characterization f 
the tissue was carried out by microscopic examina- 
tion of a pathologist within 1-2 h after surgery. For 
the protein kinase determ~ation the breast issue was 
pulverized in liquid nitrogen. The powdered tissue 
was then homogenized in4 parts (w/v) of ice-cold 
10 mM Tris-HCl buffer containing 1.5 mM EDTA, 
6 mM 2-mercaptoethanol and 10% glycerol at pH 7.4 
with a Polytron PT-20 (Brinkmann Instruments) at 
low speed (setting4). The homogenate was centrifuged 
for 60 mm at 105 000 X g. The supematant fraction 
was recovered and chromatographed on DEAE- 
cellulose. cam-sensitive protein kinase activity was 
measured as in [2 l] using protamine sulfate as sub- 
strate in the presence of 3.3 PM CAMP with and with- 
out heat-stable protein kinase inhibitor. The inhibitor 
was isolated from rabbit skeletal muscle by the 
method in [22]. Partial purification of the inhibitor 
was carried out by heat-treatment of the muscle 
extract followed by trichloroacetic acid precipitation. 
Protein was determined by the Lowry method [23]. 
The tissue was classified according to the criteria 
given by the World Health Org~ization 1968 1241. 
The cellular density was evaluated by counting no. 
nuclei/ 1000 pm2 tissue in 4 different issue areas per 
biopsy [15]. 
3. Results 
In view of the m~tiplicity of cup-de~ndent 
protein kinase isozyme pattern in a given tissue, we 
analyzed the cytosol fraction of normal (simple 
dysplasia) and neoplastic human mammary tissue by 
DEAE-cellulose chromatography (fig.1). 
In all of the elution profiles protein kinase activity 
was resolved into two major peaks of CAMP-depen- 
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Fia.1. Comparative DEAE-cellulose elution profiles of CAMP- 
dependent protein kinase obtained from the cytosols of nor- 
mal (A) and neoplastic (B) human breast tissue. Pooled cyto- 
sols of equal amounts of soluble protein (normal tissue: 
30 mg protein; neoplastic tissue: 15 mg protein) were applied 
to a DEAE-ceUulose column (1.2 X 4.0 cm). After extensive 
washing with 0.05 M NaCl in 10 mM Tris-HCI buffer (pH 7.4) 
containing 6 mM 2-mer~~toeth~o1, elution was carried out 
with a linear 0.05 -0.50 M NaCl gradient (80 ml) in the 
same buffer. Fractions (1 ml) were collected and 0.1 ml 
aliquots were assayed for protein kinase activity in the presence 
of 3.3 nM cAMPwith and without 80 pg heat-stable inhibitor. 
The profiles represent he difference of protein kinase 
activities obtained without and with the heat-stable inhibitor. 
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dent protein kinase activity eluted at 0.08-0.11 M 
NaCl, designated as peak P&I, and protein kinase 
activity eluted at 0.14-0.22 M N&l, designated as 
peak PK-II (fig.1). According to their relative lution 
positian from DEAE-cellulose , which is known to 
separate type I and type IL isozymes [17], based on 
the different st~ulation by 0.5 M NaCl [ 18], due to 
the finding that fractions PK.1 and PK-fZ bound CAMP 
specifically (data not shown) and were inhibited by 
the hea&stable rabbit skeletal muscle inhibitor, we 
conclude that type I CAMP-dependent protein kinase 
isozyme eluted with the PK.1 fraction and type II 
isozyme with the PK-II fraction, The elution profiles 
shown in fig.1 A,B represent the protein kinase 
activities calculated from the difference of enzyme 
activity stimulated by 3.3 yM CAMP in the absence 
and presence of the heat-stable i~bitur. About 
25-30% of the protein kmase activity of normal and 
neoplastic tissue is not inhibited and can be considered 
as CAMP-insensitive. 
A quantitative relationship between the specific 
activities of normal and neoplastic tissue can be 
established by calculating the specific activities of each 
isozyme peak for each DEAE-cellulose profile. The 
estimated specific activities were calculated by 
obtaining the sum of the CAMP-dependent protein 
kinase activities present in each fraction. Table 1 
shows that the estimated specific activity of neo- 
plastic tissue is 4-fold higher as compared to normal 
tissue I 
Although both isozymes were present and identified 
in normal as well as in neoplastic tissue, a 2-fold 
increase of the type I/type II ratio is obtained for the 
neoplastic tissue (table 1). Such a ratio increase appears 
to be due to an increase of type X isozyme @‘K-I) in 
neoplastic tissue (fig.lB). Type II isozyme is the 
predominant protein kinase in normal tissue, where 
only small amounts of type I can be resolved after 
DEAE-cellulose chromatography (fig.lA). 
The specific activities of type I and type II iso- 
zymes measured in the cytosol fractions do not take 
into account he marked variations of cellular densities 
innormal(l81+ 0.64 ~eUs~l0~ pm’) and neoplastic 
tissue (5.60 f 2.29 cells/l 000 pm2). When the pxo- 
tein kinase activity is expressed as relative nzyme 
levels per cell, the neoplastic tissue is not characterized 
by a decrease of CAMP-dependent protein kinase 
activity per cell (table l), as reported [ 151. This 
difference can be explained by the preferential loss of 
type I isozyme in frozen cytosols stored over longer 
periods of time (unpublished result). 
4. Discussion 
Our results indicate that the specific activities of 
type I and type II isozyme are significantly higher in 
human breast cancer tissue than in normal mammary 
tissue provided the protein kinase is compared per 
unit weight of cellular protein. ff the 3-fold increase 
of cellular density in neoplastic tissue is taken inta 
account, the relative cellular level of type I isozyme 
in neoplastic mammary tissue is 2-fold higher as com- 
pared to the relative cellular level in normal tissue, 
whereas the relative cellular activity of type II iso- 
zyme is the same in neoplastic as in normal tissue. 
This fmding is in contrast o f25f where no type I 
protein kinase could be shown in the growing and 
regressing DMEA-educed rat mammary tumor but is 
in accordance with f14] where type I protein kinase 
Table 1 
Cyclic AMP-dependent protein kinase type I and type II in human breast tissue 
Tissue protein kinase act. (pm01 “P lncorp./min x mg prot.) Rel. act&&l Isozyme ratio 
Type I Type If type I/type If 
SimpIe dyspfasia (81 91-8 * 43.9 21.9 ?. 10.7 69.9 f 33.2 5.1 f 2.4 O-32 * OS3 
Carcinoma (9) 369.2 t 66.8 141.8 t 25.5 227.5 * 41.3 6.6 f 1.2 0.63 + 0.17 
Each value is the mean f SD. The number of tissue biopsies examined is given in parentheses. The protein 
kinase represents the difference between the activity resolved after DEAE-cellulose elution in the presence of 
3.3 NM CAMP without and with 80 pg heat-stable rabbit muscle inhibitor. The protein klnase activity per cell 
was calculated by dividing the total specific activity through the respective cellular densities (simple dysplasia 
1.81 f 0.64; carcinoma 5.60 i: 2.29) 
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was found to be augmented during mitosis. This 
suggests a positive correlation between the isozyme 
ratio of type I/type II and cell proliferation rate. 
Our data, considered in context with previous 
findings, imply a possible role of the interrelation- 
ship between CAMP-dependent protein kinase type I 
and type II in the growth regulation of human breast 
tumors. Further studies on the various types of pro- 
tein kinases and their role in human mammary tumor 
growth are underway. 
Acknowledgements 
This research was supported by the Swiss Cancer 
Liga grant no. FOR. 125. AK. 78 (2). 
References 
[ 11 Kuo, J. F. and Greengard, P. (1969) Proc. Natl. Acad. 
Sci. USA 64,1349-1355. 
(21 Krebs, E. G. (1972) Curr. Top. Cell Reg. 5,99-133. 
[ 31 Langan,T. A. (1973) Adv. Cyclic Nucl. Res. 3,99-153. 
[4] Rubin, C. S. and Rosen, 0. M. (1975) Ann. Rev. Bio- 
them. 44,831~887. 
[5] ChoChung, Y. S. and Redler, B. H. (1977) Science 197, 
272-275. 
[6] ChoChung,Y. S. and Doud,F. J. (1978) Cancer Lett. 
5,219-224. 
[ 71 Liu, A. Y. C. and Greengard, P. (1976) Proc. Natl. Acad. 
Sci. USA 73,568-572. 
[8] Fuller, D. J. M., Byns, C. V. and Russel, D. H. (1978) 
Proc. Natl. Acad. Sci. USA 75,223-227. 
[ 91 ChoChung, Y. S., Bodwin, J. S. and Clair, T. (1978) 
Eur. J. Biochem. 86,51-60. 
[lo] Corbin, J. D., Kelly, S. F., Soderling, T. R. and Park, 
C. R. (1975) Adv. Cyclic Nucl. Res. 5, 265-279. 
[ 111 Rosen, 0. M., Erlichman, J. and Rubin, C. S. (1975) 
Adv. Cyclic Nucl. Res. 5, 253-263. 
[ 121 Lee, P. D., Radloff, D., Schweppe, J. S. and Jungmann, 
R. A. (1976) J. Biol. Chem. 251,914-921. 
[ 131 Eppenberger, U., Roos, W., Fabbro, D., Sury, A., Weber, 
J., Bechtel, E., Huber, P. and Jungmann, R. A. (1979) 
Eur. J. Biochem. 98,253-259. 
[ 141 Costa, M., Gerner, E. W. and Russel, D. H. (1976) 
J. Biol. Chem. 251, 3313-3319. 
[ 151 Eppenberger, U., Talmadge, K., Kting, W., Bechtel, E., 
[16! 
1171 
[I81 
[I91 
[201 
I-211 
1221 
1231 
v41 
[251 
Preisz, J., Huber, P., Jungmann, R. A. and Salokangas, 
A. (1977) FEBS Lett. 80, 229-234. 
Kting, W., Bechtel, E., Geyer, E., Salokangas, A., 
Preisz, J., Huber, P., Torhorst, J., Jungmann, R. A., 
Tahnadge, K. and Eppenberger, U. (1977) FEBS Lett. 
82,102-106. 
Tao, M., Salas, M. L. and Lipman, F. (1970) Proc. 
Natl. Acad. Sci. USA 67,408-414. 
Corbin, J. D., Keeley, S. L. and Park, C. R. (1975) 
J. Biol. Chem. 250, 218-225. 
Hoffmann, F., Beavo, J. A., Bechtel, P. J. and Krebs, 
E. G. (1975) J. Biol. Chem. 250,7795-7801. 
Sugdon, P. II., Holladay, L. A., Reimann, E. M. and 
Corbin, J. D. (1976) Biochem. J. 159,409-422. 
Talmadge, K., Bechtel, E., Salokangas, A., Huber, P., 
Jungmann, R. A. and Eppenberger, U. (1975) Eur. 
J. Biochem. 60,621-632. 
Walsh, D. A., Ashby, C. D., Gonzales, C., Calkins, D., 
Fisher, E. H. and Krebs, E. G. (197 1) J. Biol. Chem. 
246,1977-1985. 
Lowry, 0. H., Rosebrough, N. J., Farr, A. L. and 
Randall, R. J. (1951) J. Biol. Chem. 193, 265-275. 
Scraft, R. W. and Torloni, H. (1968) Histological 
typing of breast tumors, WHO, Geneva. 
ChoChung, Y. S., Clair, T. and Zubialde, J. P. (1978) 
Biochem. Biophys. Res. Commun. 85,1150-l 155. 
304 
